Preparing for a cell culturing industry

Anticipating new drug approvals that could show up as soon as 2017, the bioprocessing industry is gradually assembling the pieces that will, in fact, constitute a new form of pharmaceutical manufacturing: cell culturing, a.k.a. regenerative medicine, a.k.a. stem cell processing. […]

Read More